OUTCOMES: MINIMALLY INVASIVE LUMBAR FUSION AND DECOMPRESSION, ENDOSCOPY ASSISTED
At the Spine Institute Northwest, our goal is to provide quality care to all our patients. To ensure we are providing best possible care, we track the outcomes of all procedures done at our clinic.
We evaluate short- and long-term postoperative complications, the satisfaction level of our patients, the efficacy of the procedures and techniques used, our patients’ return to work prospective, postoperative medication dependency, perioperative data, and much more.
The data gathered is used to analyze areas that need improvement and to share the effectiveness and the safety of minimally invasive spine surgery, regenerative therapy, and other procedures done at the Spine Institute Northwest.
ONGOING RESEARCH:
BACKGROUND: Endoscopic-assisted lumbar decompression is a minimally invasive spine surgery which has been touted to reduce collateral tissue damage, incisional pain, recovery time and complications. Residual back or leg pain and recurrent herniation are commonly reported post-operative outcomes. It has been suggested that injecting orthobiologics like cryopreserved amniotic-derived products (ADPs) and bone marrow aspiration (BMA) into the surgery site would have additional benefit on patient outcomes. This is a Western Institutional Review Board (WIRB)-approved level 1, randomized controlled trial of prospectively collected patient demographic and outcomes data for endoscopic-assisted lumbar decompression surgery. The primary goal of this study was to compare patient outcomes of orthobiologic supplementation during endoscopic-assisted lumbar decompression surgery.
DATA:
CLICK TO READ PUBLICATION AND DATA HERE
BACKGROUND:
Full Endoscopic Lumbar Fusion Outcomes in Patients With Minimal Deformities: A Retrospective Study of Data Collected Between 2011 and 2015. Methods: This Western Institutional Review Board-approved study (#1-925640-1) assessed blood loss, operative time (OR time), post anesthesia care unit time (PACU time), and Visual Analog Scale (VAS) of 85 patients who underwent FE-TLIF between 2011 and 2015 and were followed up for 12 months. Relationships between risk factors (demographics, clinical presentation) and outcomes were analyzed.
Kamson S, Lu D, Sampson PD, Zhang Y.
DATA:
CLICK TO DOWNLOAD PRESENTATION AND DATA HERE
BACKGROUND:
Prospective Ongoing Study of 32 Patients
Authors: Solomon Kamson, MD. Yelena Verbitskaya, BSN. Spine Institute NW
*** Presented at Conference: 7th Turkmiss Meting and World Congress of WFMISS Istanbul 2014
DATA:
CLICK TO DOWNLOAD PRESENTATION AND DATA HERE
*** Presented at Conference: 7th Turkmiss Meeting and World Congress of WFMISS Istanbul 2014